Kolexia
Magrin Elisa
Pharmacien
Hôpital Necker Enfants Malades
Paris, France
66 Activités
159 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose Thalassémie Bêta-Thalassémie Syndrome de Wiskott-Aldrich Hémoglobinopathies Anémie Immunodéficience combinée grave Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémies

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   08 janvier 2024
Cryopreservation Impacts Allogenic Stem Cell Engraftment: Relation between Graft Quality Control and Post-Transplant Clinical Outcome
65th ASH Annual Meeting Abstracts   02 novembre 2023
Preclinical Assessment for Gene Addition Strategy in Familial Hemophagocytic Lymphohistiocytosis Related to Munc 13-4 Deficiency
65th ASH Annual Meeting Abstracts   02 novembre 2023
Human Pro-T-Cell Manufacturing in Vitro Is a Safe Procedure for Hematopoietic Stem Cell Transplantation with Delayed T-Cell Reconstitution: Interim Results from 2 Different Clinical Trials
65th ASH Annual Meeting Abstracts   02 novembre 2023
Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
Essai Clinique (Bluebird)   13 octobre 2023
Sickle Cell Disease: From Genetics to Curative Approaches.
Annual review of genomics and human genetics   28 août 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy.
Cell reports. Medicine   26 janvier 2023
HTLP-ONCO: A Phase I/II Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies
Essai Clinique (Assistance publique – Hôpitaux de Paris)   31 octobre 2022
Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.
Nature medicine   15 octobre 2022
Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
Bone marrow transplantation   11 mai 2022